Get started Log in

NXGL — Nexgel Share News

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMicro CapValue Trap

Market Cap
$2.45m
Enterprise Value
$6.34m
Revenue
$11.42m

Brief: Nexgel Reports Second Quarter 2022 Financial Results
10/08/2022 22:11
Brief: Entera Bio Announces Execution Of Key Regulatory Milestones For Eb613, The First Oral Anabolic Drug Proposed For The Treatment Of Osteoporosis Miranda Toledano Assumes CEO Position
18/07/2022 12:10
Brief: Entera Bio Board Member, Miranda Toledano, To Assume Role Of Chief Business Officer, Chief Financial Officer, And Head Of Corporate Strategy
16/05/2022 13:12
Brief: Nexgel Reports First Quarter 2022 Financial Results
12/05/2022 22:28
Brief: Nexgel Inc Files For Mixed Shelf Of Up To $75 Million – SEC Filing
13/04/2022 22:33
Refile: BUZZ- Nexgel set for best day on launching hydrogel patch to treat foot blisters
12/01/2022 13:25
Brief: Nexgel Announces The Launch Of Medagel ClearComfort Hydrogel Patch
12/01/2022 13:20
Brief: Nexgel Announces Closing Of $14.2 Million Initial Public Offering
27/12/2021 21:21
NASDAQ RESUMED AT 11:25 AM
22/12/2021 16:25
NASDAQ TRADE HALT CONTINUES VOLATILITY TRADING PAUSE AT 11:20 AM
22/12/2021 16:21
NASDAQ RESUMED AT 11:16 AM
22/12/2021 16:16
NASDAQ RESUMED AT 11:15 AM
22/12/2021 16:15
NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 08:28 AM
22/12/2021 13:28
NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 08:28 AM
22/12/2021 13:28
NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:58 AM
22/12/2021 08:59
NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:58 AM
22/12/2021 08:59
Brief: Nexgel Announces Listing On Nasdaq And Pricing Of $14.2 Million Initial Public Offering
22/12/2021 01:09